http://www.fda.gov/cder/orange/appendix_a.txt
1/35 28, ETHINYL ESTRADIOL NABUMETONE, NABUMETONE NADOLOL, NADOLOL NAFAZAIR, NAPHAZOLINE HYDROCHLORIDE NAFCILLIN SODIUM, NAFCILLIN SODIUM NAFTIN, NAFTIFINE HYDROCHLORIDE NALBUPHINE HCL, NALBUPHINE HYDROCHLORIDE NALBUPHINE, NALBUPHINE HYDROCHLORIDE NALFON 200, FENOPROFEN CALCIUM NALFON, FENOPROFEN CALCIUM NALIDIXIC ACID, NALIDIXIC ACID APPENDIX A PRODUCT NAME INDEX NALLPEN IN PLASTIC...
Prescription and OTC Drug Product List 11/2001
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET; ORAL PERCOCET -A- + ENDO PHARMS 325MG;7.5MG N40434 001 NOV 23, 2001 NOV NEWA -A- + 325MG;10MG N40434 002 NOV 23, 2001 NOV NEWA ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE -A- AB ANABOLIC 325MG;50MG;40MG;30MG...
Prescription and OTC Drug Product List 1/1998
Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 1: Jan 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACARBOSE ALPROSTADIL TABLET; ORAL INJECTABLE; INJECTION PRECOSE PROSTIN VR PEDIATRIC - DLT - @ BAYER 25MG N20482 004 - DLT - + PHARMACIA AND UPJOHN 0.5MG/ML N18484 001 - DLT - MAY 29, 1997 - ADD -...
Prescription and OTC Drug Product List 5/2001
MIDAZOLAM HCL - DLT - AP + B BRAUN 500MG/100ML N18674 001 - DLT - AP APOTHECON EQ 1MG BASE/ML N75620 001 - DLT - AUG 31, 1982 - DLT - NOV 01, 2000 - ADD - @ 500MG/100ML N18674 001 - DLT - AP EQ 5MG BASE/ML N75620 002 - ADD - AUG 31, 1982 - DLT - NOV 01, 2000 - DLT - METRONIDAZOLE - DLT - AP EQ 5MG BASE/ML N75641 001 - DLT - AP + ABBOTT 500MG/100ML N18889 001 - DLT - OCT 19,...
Mercury in Drug and Biologic Products
Long Acting Nasal Spray PMA.002 - Drug Guild Distributors Long Acting Nasal Spray Kolex LA PMA.002 - DRX Pharmaceutical Blephamide Ophthalmic Ointment PMA NS - DRX Pharmaceutical Cortisporin Ophthalmic Suspension TM.001 - DRX Pharmaceutical Neomycin Polymyxin B Sulfates Hydrocortisone Ophthalmic Suspension TM NS - DRX Pharmaceutical Neomycin Polymyxin ...
Microsoft Word - Medication_Listing.doc
(ASL- 04) framycetin/ gramicidin/ dexamethasone eye ointment, each gram: (Sofracort®) 5 mg framycetin 0.05 mg gramicidin 0.5 mg dexamethasone eye drops, each mL: 5 mg framycetin 0.05 mg gramicidin 0.5 mg dexamethasone 52: 08 Anti- Inflammatory Agents dexamethasone (Maxidex®) 0.1% eye/ ear drops fluticasone MDI (Flovent®) 125 mcg/ dose 250 mcg/ dose flumethasone ...
author: Wendy Daws
Microsoft Word - Master_Index.doc
S.®) 14 28: 08.08 morphine sulfate sustained release (MS Contin®, M- Eslon®) Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 14 28: 08.08 morphine sulphate 14 28: 08.08 Motilium® 28 56: 40 Motrin® 16 28: 08.04 MS Contin® Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 01) 14 28: 08.08 multivitamin 36 88: 28...
author: Wendy Daws
Microsoft Word - Master_Index.doc page 35
author: Wendy Daws
Microsoft Word - Master_Index.doc page 1
author: Wendy Daws
Microsoft Word - Master_Index.doc
Continuing Care Pharmacy & Therapeutics Formulary ML- Index SECTION SUBJECT Page 35 of 58 MASTER INDEX Medication Listing Index YY MM DD Original 00 10 30 Revised 01 12 19 Revised 03 10 23 DRUG NAME PAGE CLASS nadolol (Corgard®) 9 24: 04 naloxone (Narcan®) 15 28: 10 13 28: 08.04 naproxen (Naprosyn®) 13 28: 08.04 15 28: 10 Nebcin® injection 1 8: 12.02 Nebcin®...
author: Wendy Daws
4:00 page 29
author: Christine Wildman
material_safety_data_sheet_letter_new_.doc
® (Fluorometholone, Ophthalmic Ointment) 0.1% ALBALON® (Naphazoline HCl Ophthalmic Solution) 0.1% FML- S® (Fluorometholone, Sulfacetamide Sodium Ophthalmic Suspension) ALLERGAN® Eye Wash Gentamicin Sulfate, 0.3% ALOCRILO (Nedocromil Sodium Ophthalmic Solution 2%) HYLAFORM® (Hylan B Gel) BLEPH- 10® (Sulfacetamide Sodium Ophthalmic Solution) 10...
author: hutton_ronald
material_safety_data_sheet_letter_new_.doc page 2
author: hutton_ronald
Antibiotics
-- Search - Biochemicals Amino Acids Antibiotics Biological Buffers Detergents Enzyme Substrates Inorganic Reagents Molecular Biology Organic Reagents Stains & Dyes Vitamins ---- You are here: Home » Biochemicals » Antibiotics Antibiotics 1 - 46 of 46 1 17-AAG... ')" onMouseOut="hideTip()" href="Product.aspx?ProdId=24401">Ascomycin A3680 Highly Purified Form:-- Supplied...
What's new at CDER by Date
- U.S Commit (nicotine polacrilex) Lozenge, GlaxoSmithKline Dextrose Injection USP, B Benazepril Hydrochloride & Hydrochlorothiazide Tablets, Genpharm Benazepril Hydrochloride & Hydrochlorothiazide Tablets, Ivax Pharmaceuticals Intal (cromolyn sodium) Inhaler, Aventis Pharmaceuticals Intal (cromolyn sodium) Nebulizer, Aventis Pharmaceuticals Mercaptopurine Tablets,...
author: Paul Stauffer
Drug Approvals - M
NDA 13-422/S-035 4/17/03 - - - Maxipime (Cefepime Hydrochloride) Injection,-Rx Bristol-Myers Squibb NDA 50-679/S-21 3/17/03 3/26/03 3/26/03 Maxipime (Cefepime Hydrochloride) Injection,- Bristol-Myers Squibb NDA 50-679/S-009, S-014 and S-018 8/21/02 8/26/02 - Maxipime (Cefepime Hydrochloride) Injection Bristol-Myers Squibb NDA 50-679/S007 1/27/99 - - 7/18/01 Maxitrol (neomycin ...
Drug Approvals - N
Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted Nabumetone Tablets, 500 mg, Rx- Second (Tentative Approval) Copley Pharmaceutical, Inc ANDA 76-302 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Rx, Tentatively Approved Eon Labs, Inc ANDA 76-072 1/30/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
API DIVISION" "AMOXICILLIN MFG IN MEXICO, MISSOURI" 13520 01-Sep-98 ANTIBIOTICOS TETRACYCLINE PHOSPHATE COMPLEX 13521 01-Sep-98 KYOWA HAKKO MITOMYCIN 13523 01-Sep-98 GIST BROCADES (IT) NYSTATIN 13527 01-Sep-98 BRISTOL MYERS SQUIBB INDUSTRIAL DIV AMIKACIN SULFATE 13535 01-Sep-98 MEIJI SEIKA KAISHA L PENICILLIN G PROCAINE 13536 01-Sep-98 ALPHARMA APS POLYMYXIN B ...
Genzyme Tissue Repair
Agent Maximum Dose* Agent Maximum Dose* Amphotericin B 24 µg/ ml Polymyxin B Sulfate 1000 U/ ml Cefoperazone 100 µg/ ml Polymyxin B Sulfate & Bacitracin zinc 200 U/ ml, 10 U/ ml Ciprofloxacin 5 µg/ ml Polymyxin B Sulfate, Bacitracin zinc and Neomycin Sulfate 100 U/ ml, 25 U/ ml, 0.6 mg/ ml...
author: MIS
Genzyme Tissue Repair page 5
author: MIS
Prescription and Over-the-Counter Drug Product List: 10/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA VINTAGE PHARMS 500MG/15ML;7.5MG/15ML N40520 001 OCT 30, 2003 OCT NEWA TABLET; ORAL ANEXSIA >D> AA MALLINCKRODT 750MG;10MG N40468 001 OCT 31, 2002 OCT CTNA >A> AA 750MG;10MG N40468 001 OCT 31, 2002 OCT CTNA ALBUTEROL SULFATE ...
Prescription and Over-the-Counter Drug Product List: 2/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL -A- CODRIX -A- + ANDRX PHARMS 500MG;15MG N40447 001 FEB 26, 2003 FEB NEWA AZATHIOPRINE TABLET; ORAL AZASAN -A- AAIPHARMA LLC 25MG N75252 002 FEB 03, 2003 FEB NEWA -A- AB 50MG N75252 001 JUN 07, 1999 FEB NEWA -A- 75MG N75252 003 FEB 03, 2003 FEB NEWA -A- 100MG N75252 004 FEB 03, 2003...
author: AUTHOR
Prescription and OTC Drug Product List 7/2001
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE -A- AB ABLE 325MG;50MG;40MG N40390 001 JUL 23, 2001 JUL NEWA -A- AB 500MG;50MG;40MG N40394 001 JUL 23, 2001 JUL NEWA ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- AA + WATSON LABS 325MG;7.5MG...
Prescription and OTC Drug Product List 6/2002
-D- + WYETH AYERST 20,000 UNITS/VIAL N17055 003 JUN DISC -A- @ 20,000 UNITS/VIAL N17055 003 JUN DISC CHORIONIC GONADOTROPIN -D- + STERIS 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC -A- @ 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC GRANISETRON HYDROCHLORID E SOLUTION; ORAL KYTRIL -D- + ROCHE EQ 2MG BASE/10ML N21238 001 JUN 27, 2001 JUN DISC -A- @ EQ 2MG BASE/10ML N21238...
http://www.fda.gov/cdrh/pdf2/k022584.pdf page 1